Skip to main content

01.10.2013 | Research | Ausgabe 5/2013 Open Access

Critical Care 5/2013

Pattern of Brain Injury in the Acute Setting of Human Septic Shock

Critical Care > Ausgabe 5/2013
Andrea Polito, Frédéric Eischwald, Anne-Laure Le Maho, Angelo Polito, Eric Azabou, Djillali Annane, Fabrice Chrétien, Robert D Stevens, Robert Carlier, Tarek Sharshar
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​cc12899) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AndP conceived of the study, helped acquire data, and wrote the manuscript. FE, aided in acquisition of data. ALM, acquired data. AngP performed the statistical analysis and helped to draft the manuscript. EA, acquired data. DA, helped in interpretation of data. FC helped in interpretation of data. RS conceived of the study and helped to revise the manuscript. RC participated in coordination of the study and the acquisition and interpretation of data. TS conceived of the study and wrote the manuscript.
All authors read and approved the final manuscript.
apparent diffusion coefficient
adaptation to the intensive care environment
blood-brain barrier
confusion assessment method for the ICU
disseminated intravascular coagulation
diffusion-weighted imaging
echo-planar imaging
fluid-attenuated inversion recovery
Glasgow Coma Scale
Glasgow Outcome Scale
intensive care unit
mean blood pressure
magnetic resonance imaging
magnetization transfer contrast
prothrombin time
partial thromboplastin time
Richmond Agitation Sedation Scale
oxygen saturation
New Simplified Acute Physiology Score
Sequential Organ Failure Assessment.


Brain dysfunction is a frequent and severe complication of septic shock, as it occurs in up to 60% of patients [1, 2] and is associated with increased mortality [3] and long-term cognitive impairment [4, 5]. It is clinically characterized by an acute alteration of consciousness, ranging from coma to delirium, and less frequently by seizures or focal neurologic signs [1, 6]. The neuroradiologic correlates of these symptoms are poorly known, as few imaging studies have been carried out in septic-shock patients. In a preliminary study of nine septic-shock patients who underwent a brain MRI because of an acute neurologic alteration, we found ischemic stroke and confluent or diffuse white matter lesions (which we called leukoencephalopathy) in two and five patients, respectively [7]. These findings provided insight into the pathophysiology of sepsis-related brain dysfunction. The demonstration of ischemia suggests the importance of cerebral perfusion impairment and microcirculatory dysfunction, whereas leukoencephalopathy is indicative of a range of pathologic processes including impairment of the blood-brain barrier, axon loss, gliosis, dilated perivascular spaces, and lacunar infarcts [1, 7]. Recently, one group reported abnormalities on brain imaging in two-thirds of 64 critically ill patients who developed acute neurologic changes [8]. However, only a small proportion of these patients were septic, and brain imaging was predominantly obtained by CT scan instead of MRI.
Our aim was to assess the prevalence of ischemic stroke and leukoencephalopathy and to identify their association with predisposing factors, clinical manifestations, and outcome in a cohort of septic-shock patients with acute clinical signs of brain dysfunction. It was not ethically conceivable to perform an MRI in septic-shock patients without neurological symptoms because of the risk of transport.

Materials and methods

Patients and settings

This was a prospective observational study that was conducted in an 18-bed medical and surgical intensive care unit (ICU) of a university teaching hospital (Raymond Poincaré Hospital, Garches, France). Patients were enrolled at our institution from November 2005 to June 2012. Patients were eligible for inclusion if they met the following criteria: (a) septic shock defined according to established criteria [9], and (b) evidence of acute brain dysfunction defined as the presence of any of the following: coma, delirium, focal neurologic deficit, or seizure (defined subsequently). Patients were excluded if they had any pre-existing central nervous system disease (neurodegenerative, inflammatory, and cerebrovascular disease), unstable respiratory and hemodynamic status, or contraindications to MRI. Elderly patients (older than 80 years) were not included because of the high prevalence of pre-existing white matter disease in this population. Patients with brain infection and endocarditis were excluded. The study was approved by the ethics committee of Saint-Germain-en-Laye, and informed consent was obtained from patients' closest relatives [10, 11]. The study protocol was approved by the local institutional review board, and oral informed consent was obtained from the patients' closest relatives and recorded in the patient's medical record.

Neurologic examination

Neurologic examination was performed daily by a senior neurologist (TS) and included (a) assessment of level of consciousness by using the motor and eye responses of the GCS; (b) assessment of agitation by using either the ATICE scale [12] or RASS [13]; (c) assessment of delirium by using CAM-ICU [14]; (d) cranial nerve examination, that is, pupillary size (miosis, normal, or mydriasis) and response to light, and evaluation of grimace; in comatose or sedated patients assessment included resting eye position (normal or abnormal), spontaneous eye movement (present or absent), blink response to strong light, corneal reflexes, grimacing in response to retromandibular pressure, oculocephalic reflex, and cough reflex after tracheal suctioning; and e) patellar and bicipital deep tendon reflexes and plantar reflexes. Coma was defined as GCS <8 in non-sedated patients or after 3 days of discontinuation of sedation in previously sedated patients [15]. Seizures were defined as generalized or focal (face or limb) tonic or clonic movement or recurrent twitching of one limb or eyelid twitching. Any lateralized deficit was considered a focal neurological deficit.

Brain magnetic resonance imaging

Vital signs including blood pressure, electrocardiogram (ECG), and pulse oximetry were monitored continuously during MRI (Maglife Bruker MR compatible monitoring), as described elsewhere [7]. The duration of MRI examination ranged from 30 to 45 minutes. None of the patients experienced physiological or neurological deterioration during MRI procedures or during transport.
MRI was performed on a 1.5-T scanner (Intera; Philips, Eindhoven, The Netherlands) and included sagittal gradient echo T1-weighted, axial turbo spin echo with fluid-attenuated inversion recovery (FLAIR), T2-weighted, and axial echo-planar imaging (EPI) diffusion-weighted imaging sequences. All axial images were acquired parallel to the neuroophthalmic plane. Diffusion-weighted imaging (DWI) was performed with diffusion gradients applied along three orthogonal axes and a b factor of 1,000 ms. Data obtained from these images were used to construct isotropic DWI images and apparent diffusion coefficient (ADC) maps. Other imaging included T1-weighted imaging with contrast injection (Gadoterate meglumine, Gado dota, DOTAREM; Guerbet Laboratory, Aulnay-sous-Bois, France; 0.1 mmol/kg), and with magnetization transfer contrast (MTC), time-of-flight MR angiography, and perfusion imaging. This MRI protocol was designed to maximize sensitivity to hemorrhage, ischemic stroke, and white matter lesions (that is, leukoencephalopathy).
MRI results were categorized as normal or abnormal. In contrast to our previous report, we classified white matter lesions as significant when patchy, confluent, or diffuse. Punctiform white matter lesions were considered not pathologic.

Brain complementary investigations

In patients with ischemic stroke, a standard ECG, an echocardiography, and a carotid Doppler were performed. In patients with arrhythmias, continuous electrocardiographic monitoring (Spacelabs Health Care, Ultraview SL, Washington, DC, USA) was also performed. According to Toast classification, patients were eventually classified as either having or not cardioembolic and/or atherosclerosis (thromboembolic) episode [16]. All patients who showed clinical signs of coma, delirium, or seizure underwent EEG examination. Every EEG received a score between 0 and 5 by a senior neurophysiologist (EA) and classified according to Synek score as benign (grade 0 to 2), uncertain (grade 3), or malignant (grades 4 and 5) [17].

Definition of variables and outcomes

Demographic characteristics, known risk factors for cardiovascular disease (that is, smoking, hypertension, coronary artery disease, diabetes, hypercholesterolemia, hypertriglyceridemia, and stroke), estimated prognosis of pre-existing underlying illness (graded as nonfatal, ultimately, and rapidly fatal disease), date and category of admission (medical or surgical) in the ICU, SAPS-II as well as microbiological data were recorded at admission. From admission to the day of MRI, SOFA score, vital signs, type and dose of catecholamine infused, sedatives, analgesics and antibiotics, use of steroids, days of mechanical ventilation, and standard laboratory tests were recorded daily. Hypotension was defined as a mean arterial pressure <60 mm Hg; oxygen desaturation was defined as an SaO2 <90%. The duration (days) of catecholamines infusion, maximum and minimum systolic and mean blood pressure, time (hours) spent with MBP <60 mm Hg or with SaO2 <90%, and maximal SOFA score were also recorded. According to the International Society of Thrombosis and Haemostasis, DIC was defined as a score based on alteration of routine coagulation tests (platelet count, fibrin and fibrinogen levels, prothrombin time) more than 5 [18].
The primary outcome variable was the presence of MRI signs of ischemic stroke and leukoencephalopathy in patients with septic shock and acute brain dysfunction. Secondary outcomes were represented by ICU mortality, hospital and ICU length of stay, duration of mechanical ventilation, and GOS at 6 months (dichotomized at ≤3 versus >3) [19].

Statistical analysis

STATA software, Version 11.1 data analysis and statistical software (StataCorp LP, College Station, TX, USA) was used for statistical analysis. Continuous variables are reported as median (10th and 90th percentiles) and as number (proportion) for categoric variables. Kruskal-Wallis and χ2 /Fisher Exact tests were used to determine unadjusted association between type of brain lesions and continuous and categoric variables, respectively. Additional multivariable analysis was performed by means of logistic regression to seek adjusted relations between type of brain lesions and ICU mortality and GOS at 6 months.
The selection of independent variables for the model was based on statistical significance at univariable testing. Covariates with a value of P < 0.05 were included in the multivariable analysis. The limit for statistical significance was set at P = 0.05. All tests were two-sided. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.


From November 2005 to June 2012, 170 patients were admitted for septic shock and developed acute brain dysfunction; of those, 71 (42%) patients were enrolled and underwent brain MRI, with a median time delay from acute brain dysfunction of three days. 57 (33%) patients were not enrolled because of patient's death before MRI (n = 40) or MRI contraindication (n = 17) whereas 42 (25%) were excluded from the study because of a prior central nervous system disorder, endocarditis, or age older than 80 years. CT scan was performed in 12 (17%) (Figure 1).

Patients' characteristics, neuroimaging, and outcome

Patients' characteristics are presented in Table 1. Coma was present in 33 (46%) cases, delirium in 35 (49%), focal neurologic deficit in 13 (18%), and seizure in seven (10%). Mixed neurologic deficits, defined as more than one neurological sign in the same patient, were present in 16 (23%) patients. MRI was normal in 37 (52%) patients. In 21 (29%) patients, MRI demonstrated evidence of ischemic stroke, whereas leukoencephalopathy was found in 15 (21%; Figure 2). Ischemic strokes were large in nine (43%) patients, multiple in 14 (67%) patients Figures 3 and 4), and junctional in six (29%) patients. Cardiovascular investigations evidenced a cardioembolic factor in six patients, a thromboembolic factor in eight, both in two, and none in two. They were incomplete in five patients, among whom three died rapidly. Six (8%) patients had more than one type of brain lesion at MRI. Neurologic symptoms and MRI findings did not change over the study period.
Table 1
Main characteristics between admission, inclusion, and after hospital discharge
N= 71
27 (38)
Age (years)
65 (56-76)
Cardiovascular risk factors (%)
Atrial fibrillation (%)
40 (56)
11 (16)
Blood culture (%)
17 (24)
42 (59)
   Pure Gram negative
28 (39)
   Pure Gram positive
16 (23)
SAPS II at admission
49 (38-60)
Knaus (B or more)
56 (79)
Mac Cabe (>1)
29 (41)
Admission to MRI
Delay from admission to MRI (days)
7 (2-10)
Delay from neurologic signs to MRI (days)
3 (1-5)
Highest SOFA (from 0 to 24)
13 (9-16)
Highest neurologic SOFA score (from 0 to 4)
4 (2-4)
Highest respiratory SOFA score (from 0 to 4)
3 (2-3)
Highest cardiovascular SOFA score (from 0 to 4)
3 (3-4)
Cumulative time with MBP <60 mm Hg (hours)
5 (2-8)
Highest hepatic SOFA score (from 0 to 4)
1 (0-2)
Highest renal SOFA score (from 0 to 4)
1 (0-2)
Presence of DIC (%)
34 (48)
Highest coagulation SOFA score (from 0 to 4)
2 (0-3)
Lowest/highest plasma sodium level (mM)
134 (129-136)/144 (140-148)
Lowest/highest plasma glucose level (mM)
4·6 (3.6-5.1)/12.5 (10.0-16.9)
Highest plasma lactate level (mM)
4.3 (2.4-6.0)
Lowest plasma platelets level (109/L)
96 (45-220)
Time on vasopressors (days)
4 (2-8)
Mean (nor)epinephrine infusion rate (μg/kg/min)
0.83 (0.71 - 1.62)
Insulin therapy (%)
59 (83)
Sedation (%)
Mean midazolam infusion rate (mg/h)
49 (69)
7.3 (5.1-9.0)
Duration of sedation (days)
2 (0-5)
After MRI
Length of mechanical ventilation (days)
21 (6-45)
Length of stay in the ICU (days)
31 (14-53)
23 (32)
GOS at 6 months >3(%)
37 (52)
Data are expressed in number (%) or median (IQR).
SAPS-II, New Simplified Acute Physiology Score; MRI, magnetic resonance imaging; SOFA, Sepsis-related Organ Failure Assessment; PaO2, partial pressure of oxygen in arterial blood; SaO2, oxygen saturation; MBP, mean blood pressure; DIC, disseminated intravascular coagulation; ICU, intensive care unit; GOS, Glasgow Outcome Scale
Among patients who developed only coma, delirium, or both, EEG was performed in 47 (92%) of 51 patients. Coma was associated with median EEG grade of 3.5 (3.0 to 4.0), and delirium with 3.0 (1.0 to 3.5). EEG grade >3 (malignant pattern) was significantly more frequent in patients who died (11 (69%) versus five (16%); P = 0.001) (Table 2).
Table 2
Comparison of demographic characteristics and septic-shock severity between patients with normal MRI, isolated ischemic stroke, and leukoencephalopathy
Leukoencephalopat hy
Age (years)
64 (55-75)
61 (48-78)
69 (67-75)
65 (63-74)
25 (40)
12 (32)
4 (40)
9 (56)
Cardiovascular risk factors
37 (59)
19 (51)
8 (80)
10 (62)
49 (38-60)
52 (39-60)
49 (31-60)
48 (38-55)
Admission to MRI
Highest SOFA
13 (9-16)
13 (8-15)
9 (8-12)
15 (13-16)
Highest CV SOFA
3 (3-4)
3 (3-4)
2 (2-3)
4 (3-4)
Highest nonneuro SOFA (without GCS)
10 (7-12)
10 (6-12)
8 (5-8)
11 (9-12)
Lowest MBP (mm Hg)
52 (45-55)
51 (45-56)
53 (47-63)
52 (41-54)
Cumulative time with MBP <60 mm Hg (hours)
6 (3-8)
6 (3-11)
2 (1-7)
6 (5-8)
Highest plasma PTT level
1.8 (1.4-3.2)
1.4 (1.7-3.2)
2.0 (1.3-2.2)
2.5 (1.6-4.2)
Lowest plasma platelets level (109/L)
97 (47-224)
110 (51-223)b
228 (101-351)c
50 (23-95)
28 (44)
17 (46)
2 (20)
11 (69)
After MRI
21 (33)
9 (24)b
2 (20)c
10 (62)
GOS 6 months ≤ 3
30 (48)
14 (38)b
3 (30)c
13 (81)
Data are expressed in number (%) or median (IQR). Kruskal-Wallis and Mann-Whitney tests were used for comparison of quantitative variables between three and two groups. aSignificant difference between MRI normal and leukoencephalopathy. bSignificant difference between MRI normal and ischemia. cSignificant difference between MRI ischemia and leukoencephalopathy.
SAPS-II, New Simplified Acute Physiology Score; MRI, magnetic resonance imaging; SOFA, Sepsis-related Organ Failure Assessment; CV, cardiovascular; MBP, mean blood pressure; PTT, partial thromboplastin time; DIC, disseminated intravascular coagulation; GOS, Glasgow Outcome Scale.
A comparison of patients with normal MRI (n = 37), isolated ischemic stroke (n = 16), and isolated leukoencephalopathy (n = 10) is presented in Table 3. Age, preexisting cardiovascular risk factors, severity of septic shock, and hemodynamic failure were not significantly different among these subgroups (Table 2), as well as pathogens, vasopressors, PaO2/FiO2 ratio, minimal SpO2, prothrombin time, and hemoglobin and lactate levels (data not shown). Focal neurologic deficits were more frequently associated with ischemic stroke (Table 3). Among the 47 patients who underwent an EEG, four had mixed brain lesions, and EEG grade >3 (malignant pattern) was more frequent in patients with isolated ischemic stroke or isolated leukoencephalopathy than in patients with normal MRI (6 (67%) versus 5 (50%) versus 4 (17%); P = 0.01).
Table 3
Comparison of neurologic and electroencephalographic features between patients with normal MRI, isolated leukoencephalopathy, and isolated ischemic stroke
Clinical features
GCS motor response
4 (1-6)
4 (1-6)
5 (4-6)
3 (1-4)
Neurologic symptoms
Focal neurologic signs
11 (17)
2 (5)b
1 (10)c
8 (50)b,c
31 (41)
17 (46)
2 (20)
10 (62)
6 (10)
4 (11)
0 (0)
2 (12)
31 (49)
19 (51)
7 (70)
5 (31)
EEG findings
Electrographic seizure
13 (30)
9 (38)
2 (20)
2 (22)
Slow waves
5 (11)
4 (11)
0 (0)
1 (11)
Three-phasic waves
5 (8)
1 (4)
2 (20)
2 (22)
Synek classification
3 (1-4)
3 (1-4)
2 (1-4)
4 (1-4)
EEG grade >3
15 (35)
4 (17)
5 (50)a
6 (67)b
An EEG was performed in 47 patients who developed coma, delirium, or both. Among these 47 patients, four had mixed brain lesions and were excluded from the comparison analysis.
Data are expressed in number (%) or median (IQR). Kruskal-Wallis and Mann-Whitney test were used for comparison of quantitative variables between three and two groups. aSignificant difference between MRI normal and leukoencephalopathy. bSignificant difference between MRI normal and ischemia.cSignificant difference between MRI ischemia and leukoencephalopathy.
GCS, Glasgow Coma Scale; EEG, electroencephalogram.
An association was found between ischemic stroke and lower platelet count, increased partial thromboplastin time (PTT), or presence of DIC. Twenty-one (37%) patients died in the ICU, and 22 (39%) died within 6 months from discharge (Table 2). Fourteen (67%) patients died of septic shock-related complications, including multiple organ failure, refractory hypoxemia, and refractory hypotension. Decision to limit or withdraw life-sustaining measures was made in seven (33%) patients; of those, four patients were in a vegetative state. At multivariate level, the presence of ischemic stroke was independently associated with ICU mortality (OR, 4.4; 95% CI, 1.03 to 19.0; P = 0.04) and GOS >3 at six months (OR, 6.91; 95% CI, 1.41 to 33.65; P = 0.02).


Our observational study shows that, in septic-shock patients with acute neurologic changes, brain MRI can reveal leukoencephalopathy or ischemic stroke, which is associated with increased ICU mortality and increased odds of having GOS > 3 at 6 months. We found that the prevalence of ischemic stroke (31%) is higher than previously reported by Suchyta et al. (31 versus10%, respectively) [8]. This discrepancy may be explained by the fact that in the retrospective study from Suchytha et al. [8], brain imaging was obtained by means of CT scan, thus probably underestimating the rate of brain lesions.
The occurrence of ischemic stroke in sepsis patients raises questions on the role of cerebral perfusion in this population of patients. Although some studies did not show impaired perfusion [20], others indicated a decrease in cerebral perfusion pressure or in cerebral blood flow and alterations in the regulation of cerebral perfusion, including impaired CO2-reactivity and cerebrovascular-pressure autoregulation [21]. It is plausible that the risk of stroke would be increased in patients with hypotension and impaired cerebral blood-flow autoregulation. The prevalence of watershed infarction suggests that hypotension might contribute to the occurrence of stroke.
We did not find an association between duration or severity of hypotension and cerebral ischemia in the present study or in previous neuropathologic studies [22]. However, cerebral autoregulation is altered in patients with sepsis-associated encephalopathy and would represent a better marker of cerebral hypoperfusion compared with hypotension alone [23]. Cerebral blood flow and autoregulation were not measured in our study, which was arbitrarily defined as MAP < 60 mm Hg. One way to determine the importance of cerebral perfusion in septic shock would be to determine whether perfusion monitoring and optimization reduces the prevalence of stroke. In addition to impairment of cerebral blood flow and its determinants, cerebral microcirculatory dysfunction has also been shown to be associated with brain lesions in various experimental models of sepsis but not yet in humans [1, 24], although it may probably be linked to diffuse ischemic damage and microhemorrhages observed in brains of patients who died of septic shock [22]. Our findings of significantly reduced platelet counts, increased PTT, and increased prevalence of DIC in patients with ischemic stroke suggest that the presence of coagulation derangement may be involved in the occurrence of brain lesions. Thrombosis of cerebral arteries has been reported in septic-shock patients with fulminant DIC [7]. Microcirculatory dysfunction and coagulopathy are both consequences of endothelial activation [1, 24] but are not easily preventable or treatable.
We found that a cardioembolic (essentially atrial fibrillation) or thromboembolic factor was present in 70% of patients with ischemic stroke. Interestingly, it was very recently shown that new-onset atrial fibrillation is associated with increased prevalence of stroke and mortality in sepsis patients [25]. Thus, our results suggest that ischemic stroke in sepsis patients can be favored by previous predisposing factors, result from sepsis-related particular conditions (DIC, microcirculatory alterations, and so on), or both..
Another consequence of endothelial activation is the failure of the blood-brain barrier (BBB), leading to the passage of inflammatory mediators and neurotoxic factors into the brain [1]. We hypothesized that leukoencephalopathy reflects BBB alteration, originating within the Virchow-Robin spaces and potentially propagating to other brain structures [7]. An alteration of BBB was identified neuropathologically in a patient with a diffuse leukoencephalopathy [7]. The present study confirmed that severe leukoencephalopathy is the second most frequent brain lesions (21%). We did not find a significant association between leukoencephalopathy and any specific acute neurological sign. The fact that comparable white matter lesions have not been reported in nonsepsis critically ill patients [8] is consistent with an inflammatory process. However, this pathophysiological hypothesis is not supported by our findings, as the severity of septic shock and other biologic markers of inflammation or endothelial activation did not correlate with leukoencephalopathy. That we could not find any significant association between the presence of leukoencephalopathy and severity of illness and markers of inflammation may be due to the small number of this subgroup of patients rather than a true lack of association. Moreover, we limited our analyses to conventional clinical biomarkers of inflammation and endothelial activation. More-sophisticated analysis, including plasma cytokines and adhesion molecules levels, will be warranted for future studies.
Finally, we found that the MRI was normal in 52% of our cohort of patients. Our results are consistent with those obtained by Suchyta et al. [8] in critically ill patients. The risk stratification of MRI lesions in sepsis patients might be based on the electroencephalographic pattern. Indeed, we found that malignant EEG pattern, as defined in Synek's classification, is correlated with the presence of ischemic stroke or leukoencephalopathy on MRI in comatose or delirious patients. This result suggests that EEG should be done and before MRI.
The current study has several limitations. This observational study investigated the prevalence of neuroradiologic lesions in a very selected patient population with septic shock with acute neurological symptoms, without contraindication to MRI and preexisting cerebral disease. Forty patients died before MRI could be performed. It is possible that those patients would have shown more-severe brain lesions, as suggested by postmortem neuropathologic studies [22]. The prevalence and type of brain lesion in asymptomatic patients or in those with more-subtle brain dysfunction was not analyzed. However, neuroradiologic assessment of these patients would raise some ethical issues related mainly to the risks of transporting potentially unstable patients with no neurologic signs to MRI, unless neuroimaging were performed at the time of recovery from septic shock. It has been shown that patients with sepsis are at high risk of developing long-term cognitive disability [5] and that cognitive impairment is more frequent in critically ill patients with abnormal brain imaging [8, 26, 27]. We are not able to determine either the time-to-recovery of a normal neurologic examination or the relations between neuroimaging and long-term cognitive function. Prevalence of coma, delirium, and convulsive seizures in our cohort is consistent with the prevalence previously reported in the literature [6]. Furthermore, the use of MRI with higher field strength, use of spectroscopy, and use of diffusion tensor imaging might have allowed detection of smaller ischemic lesions or other anatomic or neurochemical abnormalities.
A larger cohort of patients would allow a more accurate estimation of the prevalence of each type of brain lesion and the respective risk factors. Yet available MRI studies in septic-shock patients are scant, often retrospective, single center, and have included fewer than 10 cases [7, 8], indicating the difficulties of performing such an exploration in sepsis patients. The occurrence of focal neurologic signs, delirium, or coma, as well as prevalence of ischemic stroke and leukoencephalopathy, remained steady over the study period. No significant change in monitoring and treatment of patients with septic shock was found in our ICU during the study period. Larger multicenter studies with the standardization of both clinical and imaging protocols across centers are needed.
Finally, it is conceivable that the use of continuous or daily standard EEG would have enabled to us to detect more accurately sepsis-associated encephalopathy or nonconvulsive seizures [6].


The present study showed that the MRI is abnormal in half of septic-shock patients who developed acute brain dysfunction. Our data also showed that ischemic stroke and leukoencephalopathy are the two most frequent lesions in sepsis patients and that ischemia is associated with increased mortality and mid-term neurologic disability, defined as GOS >3. Larger multicenter cohort studies are warranted to elucidate the potential benefit of strategies aimed at manipulating both cerebral perfusion and coagulation in patients with septic shock.

Key messages

MRI can reveal leukoencephalopathy or ischemic stroke in septic-shock patients with acute brain dysfunction.
Ischemic stroke is associated with increased mortality, mid-term neurologic disability, and biological DIC.
Severity and type of neuroradiologic lesions correlate with EEG alterations.


This research received no grant from any funding agency in the public, commercial, or not-for-profit sectors.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AndP conceived of the study, helped acquire data, and wrote the manuscript. FE, aided in acquisition of data. ALM, acquired data. AngP performed the statistical analysis and helped to draft the manuscript. EA, acquired data. DA, helped in interpretation of data. FC helped in interpretation of data. RS conceived of the study and helped to revise the manuscript. RC participated in coordination of the study and the acquisition and interpretation of data. TS conceived of the study and wrote the manuscript.
All authors read and approved the final manuscript.
Authors’ original file for figure 1
Authors’ original file for figure 2
Authors’ original file for figure 3
Authors’ original file for figure 4
Über diesen Artikel

Weitere Artikel der Ausgabe 5/2013

Critical Care 5/2013 Zur Ausgabe


Neu im Fachgebiet AINS

Meistgelesene Bücher aus dem Fachgebiet AINS

  • 2014 | Buch

    Komplikationen in der Anästhesie

    Fallbeispiele Analyse Prävention

    Aus Fehlern lernen und dadurch Zwischenfälle vermeiden! Komplikationen oder Zwischenfälle in der Anästhesie können für Patienten schwerwiegende Folgen haben. Häufig sind sie eine Kombination menschlicher, organisatorischer und technischer Fehler.

    Matthias Hübler, Thea Koch
  • 2013 | Buch

    Anästhesie Fragen und Antworten

    1655 Fakten für die Facharztprüfung und das Europäische Diplom für Anästhesiologie und Intensivmedizin (DESA)

    Mit Sicherheit erfolgreich in Prüfung und Praxis! Effektiv wiederholen und im entscheidenden Moment die richtigen Antworten parat haben - dafür ist dieses beliebte Prüfungsbuch garantiert hilfreich. Anhand der Multiple-Choice-Fragen ist die optimale Vorbereitung auf das Prüfungsprinzip der D.E.A.A. gewährleistet.

    Prof. Dr. Franz Kehl, Dr. Hans-Joachim Wilke
  • 2011 | Buch

    Pharmakotherapie in der Anästhesie und Intensivmedizin

    Wie und wieso wirken vasoaktive Substanzen und wie werden sie wirksam eingesetzt Welche Substanzen eignen sich zur perioperativen Myokardprojektion? 
    Kenntnisse zur Pharmakologie und deren Anwendung sind das notwendige Rüstzeug für den Anästhesisten und Intensivmediziner. Lernen Sie von erfahrenen Anästhesisten und Pharmakologen.

    Prof. Dr. Peter H. Tonner, Prof. Dr. Lutz Hein
  • 2013 | Buch

    Anästhesie und Intensivmedizin – Prüfungswissen

    für die Fachpflege

    Fit in Theorie, Praxis und Prüfung! In diesem Arbeitsbuch werden alle Fakten der Fachweiterbildung abgebildet. So können Fachweiterbildungsteilnehmer wie auch langjährige Mitarbeiter in der Anästhesie und Intensivmedizin ihr Wissen gezielt überprüfen, vertiefen und festigen.

    Prof. Dr. Reinhard Larsen

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.